Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 2 years
- Director since
- 2025
2 years of board service in total across 1 board, counting each seat separately. Longest: Arbutus Biopharma Corporation, 1 year.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Arbutus Biopharma Corporation May 26, 202694.5%
-
Arbutus Biopharma Corporation May 21, 202595.9%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 1, 2026 | Arbutus Biopharma Corporation | Sold back to the company | −17,948 | $5.00 | $89,740 |
| Sep 18, 2026 | Arbutus Biopharma Corporation | Option exercise | +52,533 | $3.20 | $168,106 |
| Sep 18, 2026 | Arbutus Biopharma Corporation | Option exercise | +78,800 | $4.24 | $334,112 |
| Sep 18, 2026 | Arbutus Biopharma Corporation | Shares withheld for tax | −99,057 | $5.07 | $502,219 |
Questions about Robert A. Beardsley
What boards is Robert A. Beardsley on?
Robert A. Beardsley sits on the board of Arbutus Biopharma Corporation.
How long has Robert A. Beardsley served on boards?
Our records show at least 2 years of board service across 1 board, the earliest from 2025.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.